Ascend Laboratories, LLC recalls Cephalexin for Oral Suspension
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct.
- Products
-
- Cephalexin for Oral Suspension
- Company
- Ascend Laboratories, LLC
- Where it was sold
-
Nationwide in the USA.
Nationwide
- Units affected
- 10,620 - 200 mL bottles
- About this recall
- Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascent Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-544-68